Episode Details
Back to Episodes
The Copper Peptide and the Optic Nerve: A Deep Look at GHK-Cu, Oxidative Stress, and Glaucoma
Description
This audio article is from VisualFieldTest.com.
Read the full article here: https://visualfieldtest.com/en/the-copper-peptide-and-the-optic-nerve-a-deep-look-at-ghk-cu-oxidative-stress-and-glaucoma
Test your visual field online: https://visualfieldtest.com
Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support
Excerpt:
Introduction Glaucoma is a group of eye diseases where nerve cells in the retina (retinal ganglion cells, or RGCs) slowly die, causing vision loss (). In most cases, high intraocular pressure (IOP, the fluid pressure inside the eye) is a major risk factor (). Treatments currently focus on lowering IOP, but this may not always stop nerve loss (). Indeed, some patients continue to worsen despite well-controlled pressure, suggesting other factors are at work () (). Glaucoma is now understood as a multifactorial optic neuropathy – age, blood flow, immune signals, cellular stress and genetics all play roles () (). In simple terms, glaucoma damages the optic nerve (the bundle of RGC axons connecting the eye to the brain) over time, often starting in mid-life or later. While lowering eye pressure is the only proven therapy now (), scientists are looking at other pathways because vision loss can continue from aging, reduced blood supply, oxidative damage, inflammation, and other cell-level problems () (). Plain-language summary: Glaucoma is a complex disease: it usually involves high eye pressure, but also aging, blood flow problems, and damage to retinal nerve cells. Treatments lower pressure, but they don’t always protect these cells fully. What is GHK-Cu? GHK-Cu stands for a small peptide (three amino acids: glycine-histidine-lysine) bound to a copper ion. It is a natural molecule found in the body (in blood plasma and wound fluid) () (). Doctors first discovered GHK in the 1970s as a “growth factor” in human plasma that could boost tissue repair (). GHK-Cu is much studied in dermatology and wound healing: it stimulates collagen and new tissue growth in experiments () (). Its levels normally decline with age (), and people have become interested in it for its anti-aging and repair signals. Overall, GHK-Cu is considered a normal human peptide, often cited as safe and well-tolerated (). It can be applied to the skin or taken systemically in research, but there is no approved medical use yet. In this article, “systemic effects” of GHK-Cu means effects throughout the body (bloodstream, organs), not just local skin or eye treatments. Plain-language summary: GHK-Cu is a naturally occurring protein fragment that carries copper. It is known to help wounds heal and may influence genes. People study it for anti-aging, but it is not a proven medicine for anything. Overlapping Biology of GHK-Cu and Glaucoma Oxidative Stress Oxidative stress is the damage that happens when harmful oxygen molecules (free radicals) build up and overwhelm the body’s defenses. It is like cellular “rust.” High levels of oxidative stress are found in glaucoma and other nerve diseases () (). Retinal ganglion cells have very high energy needs and rich fatty membranes, making them especially vulnerable to free radicals (). Research notes that when oxidative damage occurs (for example from high pressure or aging), it can trigger inflammation and nerve injury in the optic nerve () (). GHK-Cu has multiple antioxidant actions in lab studies. In wound experiments, GHK-Cu treatment boosted levels of antioxidant enzymes and molecules like glutathione and vitamin C (). It also directly neutralizes toxic lipid-byproducts. For example, GHK-Cu can bind and inactivate harmful breakdown products